Lawsuits against Novo Nordisk often accuse the company of breach of warranty, deceptive marketing, design defects, failure to warn and gross negligence
People want safe and proven ways to manage obesity, so it helps to know the benefits and risks of each option
Patients who developed NAION while taking Ozempic report devastating consequences: Complete loss of vision in one or both eyes Permanent visual field defects Inability to drive or work Loss of independence and quality of life Need for lifetime disability accommodations Unlike gastroparesis, which can sometimes improve after stopping the medication, vision loss from NAION is typically permanent and irreversible
Drug levels fall predictably week by week, with about 50% eliminated after week 1, 75% after week 2, roughly 87.5% after week 3, less than 7% remaining by week 4, and over 97% eliminated by weeks 5 to 6, which aligns with most appetite and metabolic effects fading
Estrogen deficiency can also impact appetite regulation, according to animal studies that have linked decreased estrogen with increased hunger and a reduction in spontaneous physical activity
